Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy-Reference-Cited by-同舟云学术

Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy

Published:2019-09-27 Issue:3 Volume:59 Page:302-305
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Wang Ji-Nuo¹^ORCID,Qiu Yu¹,Niu Na²,Zhang Yan¹^ORCID,Li Jian¹^ORCID,Zhou Dao-bin¹,Cao Xin-Xin¹

Affiliation:

1. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

2. Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1670355

Reference19 articles.

1. The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases

2. Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults

3. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease

4. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

5. Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim–Chester disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns and organ treatment response of Erdheim-Chester disease with cardiac involvement;Heart;2024-05-15

2. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease;Annals of Hematology;2023-11-03

3. Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis;Orphanet Journal of Rare Diseases;2022-02-07

4. Pulmonary manifestations of Erdheim–Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis;British Journal of Haematology;2021-08-22

5. Therapy of 3 patients with Erdhiem-Chester disease with cladribin or cladribin in combination with cyclophosphamide. Case report and review of the therapy;Vnitřní lékařství;2021-05-26